These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16172231)

  • 1. Incidence trends of adenocarcinoma of the cervix in 13 European countries.
    Bray F; Carstensen B; Møller H; Zappa M; Zakelj MP; Lawrence G; Hakama M; Weiderpass E
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2191-9. PubMed ID: 16172231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening.
    Bray F; Loos AH; McCarron P; Weiderpass E; Arbyn M; Møller H; Hakama M; Parkin DM
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):677-86. PubMed ID: 15767349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention.
    Bray F; Dos Santos Silva I; Moller H; Weiderpass E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1132-42. PubMed ID: 15894663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
    Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
    J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in cancer of the cervix uteri in Sweden following cytological screening.
    Bergström R; Sparén P; Adami HO
    Br J Cancer; 1999 Sep; 81(1):159-66. PubMed ID: 10487628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995.
    Sigurdsson K
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):478-85. PubMed ID: 10376856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri.
    Nieminen P; Kallio M; Hakama M
    Obstet Gynecol; 1995 Jun; 85(6):1017-21. PubMed ID: 7770247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing trends of cervical adenocarcinoma incidence in Central Italy despite Extensive Screening Programme, 1985-2000.
    Visioli CB; Zappa M; Ciatto S; Iossa A; Crocetti E
    Cancer Detect Prev; 2004; 28(6):461-4. PubMed ID: 15582270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening.
    Mitchell H; Hocking J; Saville M
    Cancer; 2003 Dec; 99(6):336-41. PubMed ID: 14681940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing the burden of glandular carcinomas of the uterine cervix.
    Herzog TJ; Monk BJ
    Am J Obstet Gynecol; 2007 Dec; 197(6):566-71. PubMed ID: 18060938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries.
    Bray F; Richiardi L; Ekbom A; Forman D; Pukkala E; Cuninkova M; Møller H
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):652-8. PubMed ID: 16614105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix--worldwide.
    Mathew A; George PS
    Asian Pac J Cancer Prev; 2009; 10(4):645-50. PubMed ID: 19827887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of cervical cancer in Taiwan.
    Wang PD; Lin RS
    Gynecol Oncol; 1996 Sep; 62(3):344-52. PubMed ID: 8812531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer.
    Beral V; Hermon C; Muñoz N; Devesa SS
    Cancer Surv; 1994; 19-20():265-85. PubMed ID: 7534630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urbanization and the incidence of abnormalities of squamous and glandular epithelium of the cervix.
    Boon ME; van Ravenswaay Claasen HH; van Westering RP; Kok LP
    Cancer; 2003 Feb; 99(1):4-8. PubMed ID: 12589639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors.
    Vaccarella S; Lortet-Tieulent J; Plummer M; Franceschi S; Bray F
    Eur J Cancer; 2013 Oct; 49(15):3262-73. PubMed ID: 23751569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia.
    Bray F; Lortet-Tieulent J; Znaor A; Brotons M; Poljak M; Arbyn M
    Vaccine; 2013 Dec; 31 Suppl 7():H32-45. PubMed ID: 24332296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent trends in incidence of cervical cancer in several regions of south-western Europe.
    Raymond L; Ménégoz F; Fioretta G
    Rev Epidemiol Sante Publique; 1995; 43(2):122-6. PubMed ID: 7732198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
    Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.
    Barnabas RV; Laukkanen P; Koskela P; Kontula O; Lehtinen M; Garnett GP
    PLoS Med; 2006 May; 3(5):e138. PubMed ID: 16573364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.